Clemens Schotten

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best, Lars P. Bechmann, Jan‐Peter Sowa et al. · Clinical Gastroenterology and Hepatology · 2019 · 277 citations

The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma

Jan Best, H. Bilgi, Dominik Heider et al. · Zeitschrift für Gastroenterologie · 2016 · 117 citations

Engineering, Pathology, Tumor Biology +21

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients

Clemens Schotten, Bastian Ostertag, Jan‐Peter Sowa et al. · Pharmaceuticals · 2021 · 52 citations · Full text

NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization

Clemens Schotten, Lars P. Bechmann, Paul Manka et al. · Liver Cancer · 2019 · 38 citations · Full text